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Surveillance for West Nile Virus at the International Crane Foundation
2000-2004
Barry K. Hartup, International Crane Foundation, E-11376 Shady Lane Road, Baraboo, WI 53913, USA

Abstract: Between 2000 and 2004, serum samples collected annually from captive cranes at the International Crane Foundation
(ICF) were analyzed for the presence of West Nile virus (WNV) antibodies using a plaque reduction neutralization test. Eighteen
individual cranes representing 8 species were identified with positive titers (geometric mean = 188, range 40 – 1280, n = 29).
Whooping cranes (Grus americana) represented the largest proportion of seropositive individuals (33%). Flock seroprevalence
increased rapidly in 2003 and 2004 to a peak of 10%, representing a four-fold increase following index cases in 2000. None of the
seropositive cranes, however, showed clinical signs consistent with WNV-related disease during the study. The results suggest that
exposure of ICF captive cranes to WNV is relatively common and re-affirmed the decision to implement a limited vaccination plan
for hatch year whooping cranes believed to be at risk of disease from WNV.
Proceedings of the North American Crane Workshop 10:111–114
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In August 1999, West Nile virus (genus Flavivirus,
family Flaviviridae) was introduced into North America and
caused an outbreak of encephalitis in humans, birds, and
mammals in the New York City metropolitan area (Steele
et al. 2000, Marfin and Gubler 2001). The virus was first
identified from wild birds in Wisconsin during August 2001
from 2 American crows (Corvus brachyrhynchos) recovered
in Milwaukee County, southeastern Wisconsin (USGS
NWHC 2001). During 2002, the virus spread from its original
focus to encompass several southern and central counties,
including Sauk County, location of the International Crane
Foundation (ICF).
Serological and clinical findings from the initial 1999
outbreak of WNV encompassing the Bronx Zoo in New York
City suggested that a diverse array of captive cranes appeared
resistant to the virus strain that was introduced (Ludwig et al.
2002). As the disease spread, mortality in captive cranes was
limited to sandhill cranes (Grus canadensis) near large urban
centers with concurrent outbreaks in humans and wildlife. A
single sandhill crane reportedly died from WNV infection at a
zoo in Bridgeport, Conn. in fall 1999 (CDC 1999). Mortality
of 7 Mississippi sandhill crane chicks (G. c. pulla) from New
Orleans, Louisiana in 2002 was attributed to WNV.
Despite a formal safety trial in sandhill cranes of a
commercial equine WNV vaccine that showed minimal
risks (West Nile-Innovator, Fort Dodge Animal Health, Fort
Dodge, Ia.; G. H. Olsen, USGS Patuxent Wildlife Research
Center, Laurel, Md., personal communication), ICF decided
to withhold use of the vaccine for two primary reasons.
Animal care staffers were concerned about physical injury
risks to the cranes inherent with the 360 handling episodes
needed to properly immunize the entire ICF flock of nearly
120 cranes. In addition, Wisconsin state and national
surveillance data suggested a low risk of exposure in Sauk
County due to limited numbers of human, domestic animal
and wild bird cases from outside urban centers. In Wisconsin,

considerably smaller human outbreaks have been limited to
urbanized areas surrounding the cities of Milwaukee and
Madison, 90 and 50 miles distant from ICF, respectively.
Therefore, the veterinary staff began serological monitoring
of the cranes to understand the epidemiology of WNV
exposure at ICF and inform future management decisions.
The purpose of this study was to conduct annual serological
testing to document changes in flock exposure to WNV over
time and to identify species at risk of potentially developing
WNV-related disease.
Methods
Beginning in 2000, the ICF captive crane flock was
sampled annually for WNV antibodies from blood collected
during October physical examinations. Blood was collected
via jugular venipuncture, placed into serum separator tubes,
and allowed to clot. Samples were centrifuged within 1 hour,
and serum was decanted into cryovials for storage at -20o
or -80oC until analysis. Serum samples from 2000 were
shipped overnight to the New York State Animal Health
Diagnostic Center, Ithaca, New York (as part of the National
Surveillance for WNV in Zoological Institutions program).
Serum samples from 2001-2004 were taken directly to the
USGS National Wildlife Health Center, Madison, Wis. for
testing.
Both laboratories utilized a plaque reduction
neutralization test (PRNT) procedure with serial dilutions of
serum for titer determination of WNV antibodies (Lindsey et
al. 1976, Beaty et al. 1989). A reduction of 50% viral plaque
effect at a titer of >40 was considered positive. This test is
particularly useful in wildlife and exotic animals because
it does not require species-specific reagents. However, the
use of this test to specifically detect WNV antibodies is
complicated by the potential for bias from cross-reacting
antibodies to St. Louis encephalitis virus (SLEV, a native
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flavivirus) in test serum. None of the samples in this report,
except 1 tested at Cornell due to standard procedures, were
tested against SLEV to rule out false positive results. For
the analysis, however, I assumed little to no exposure to
SLEV due to the lack of human cases reported in Wisconsin
since 1981 (CDC 2007). To my knowledge, the ICF site is
not an endemic focus of SLEV activity; hence, I believe the
potential for bias in the serological findings of this study are
minimal.
The data were summarized by calculating annual
seroprevalence (no. positive/total no. tested) and the
incidence of new and repeat seropositive cranes (seropositive
2 years in a row) in the flock. A chi-square analysis for linear
trend in proportions was conducted to determine whether the
flock seroprevalence had increased over the duration of the
study (CDC 2005).
Results
Eighteen individual cranes representing 8 species
of Gruidae were identified with positive titers for WNV
antibodies between 2000 and 2004 at ICF (Table 1). The
geometric mean of the positive titers = 188 (range 40 –
1280, n = 26). Six females and 12 males were seropositive.
This difference was statistically non-significant given the
equal sex ratio of the ICF captive crane flock. All but 2 of
the seropositive cranes were adults 5 years of age or older.
The mean age of the flock during the study period was
approximately 14 years (range 4 months – 41 years); of the
seropositive cranes, 8 were younger and 10 were older than
the mean age. A seropositive hatch-year male whooping
Table 1. Species distribution of cranes with positive WNV
antibody tests at the International Crane Foundation 20002004.
No.
positive

No.
tested

Whooping crane (Grus americana)

6

52

Wattled crane (Bugeranus carunculatus)

3

9

Siberian crane (G. leucogeranus)

3

16

Hooded crane (G. monacha)

2

11

Sarus crane (G. antigone)

1

Red-crowned crane (G. japonensis)

Species

crane (G. americana) was detected in 2003 (hatch year
cranes were first tested in 2001 and ranged from 4-7% of the
cranes tested annually). A seropositive 2 year old subadult
male whooping crane was identified in 2004. Whooping
cranes represented the largest proportion of seropositive
individuals (33%), consistent with their overall proportion in
the captive flock during this time period (~25-30%). Cranes
of both wild and captive origins were seropositive. None of
the seropositive cranes showed clinical signs consistent with
WNV-related disease (Hansen et al. 2008).
The prevalence of cranes positive for WNV antibodies
increased during the surveillance period (χ2 = 13.8, P < 0.001;
Table 2). Newly seropositive and repeat seropositive cranes
were most abundant in 2003 and 2004. Five birds exhibited
repeat positive test results the year following a positive titer;
3 birds showed four- to eight-fold decreases in their titers, but
2 birds showed four-fold increases. One male Siberian crane
(G. leucogeranus) was seropositive (titer >160) for 3 straight
years. Two male wattled cranes (Bugeranus carunculatus)
had low positive titers in 2000 before WNV had officially
reached Wisconsin, and then showed considerable variation
in PRNT results in the subsequent 4 years. The first (#510, captured in eastern Africa in 1979) had titers of 80, <20,
80, 320, <20, while the second (#5-22, captured in southern
Africa in 1981) had titers of 40, <20, 20, 160, 20 from 2000
to 2004, respectively. Only the 2000 titer from #5-10 (80)
was tested against SLEV, with negative results. In addition,
a female wattled crane housed with #5-22 (#5-21, captured
in southern Africa in 1974) exhibited a low positive titer of
40 in 2002.
Discussion
An increasing number of cranes in the ICF captive
flock were found to have antibodies to WNV following
the documented arrival of the virus in Wisconsin in 2001.
Exposure to WNV occurred in 8 species, 3 of the 4 genera
Table 2. Annual serological results from WNV surveillance on
the ICF captive crane flock 2000-2004.
No.
positive

No.
new
pos.

No.
repeat
pos.

No.
tested

%
positive

2000

2

2

na

84

2.4

3

2001

0

0

0

112

0.0

1

8

2002

3

3

0

119

2.5

White-naped crane (G. vipio)

1

9

2003

9

7

2

121

7.4

Blue crane (Anthropoides paradiseae)

1

2

2004

12

8

4

119

10.1
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within the family Gruidae, was widely distributed among
cranes used for display and breeding purposes, and did not
exhibit a significant age or sex predilection based on current
flock demographics. A few individual cranes showed what
appeared to be persistent titers, or changes consistent with
re-exposure with subsequent elevations or waning titers.
Flock seroprevalence increased rapidly, approximately fourfold in 2 years following index cases in 2000. Unfortunately,
definitive identification of the first crane to develop an
elevated titer in response to WNV exposure was complicated
by the presence of low positive titers in the 3 wattled cranes
during 2000 and 2002.
I suspect that the antibody present in these wattled cranes
was either a non-specific cross-reacting antibody, such as
anti-SLEV (thus providing a false positive test result), a
waning titer from an antibody response earlier in the year, or
possibly remnant antibody from historical WNV exposure,
perhaps dating prior to capture in Africa. The 2000 results
from #5-10, however, suggest the antibody present was
specific to WNV or possibly another, unknown flavivirus.
Unfortunately, no samples exist from earlier in the same
year to aid in detection of changing titers in these cases.
Additional testing of these cranes’ banked fall serum samples
is warranted to at least establish their serological status prior
to the 1999 introduction of WNV to North America. If the
wattled crane results reported here from 2000 and 2002 are
falsely positive, then a single index case occurred during
2002 in an adult male Siberian crane, distinguished by a
elevated titer >160. This was followed by a modest increase
in the number of seropositive cranes in 2003 and 2004.
Our fall sampling strategy after mosquito season
was designed to maximize detection of rising or waning
antibody from late summer infections. The seasonal peak
in transmission of WNV in temperate areas is typically
from July to October (Gerhardt 2006). The prevalence
and magnitude of the positive titers reported in this study
appear consistent with limited, endemic exposures to
WNV. A small number of wild sandhill cranes sampled in
nearby Briggsville, Wisconsin during July to September and
beginning in 2001, first showed antibodies to WNV in 3 of 14
(21%) cranes captured in 2003 (J. A. Langenberg, Wisconsin
DNR, Madison, Wis., personal communication).
Despite flock seroprevalence surpassing 10% by 2004,
no clinical cases of WNV-related disease were documented
during the study, affirming initial observations that cranes
in general may be resistant to the introduced strain of
WNV, excepting perhaps sandhill cranes and/or young or
compromised birds. Susceptibility to disease and mortality
from WNV varies markedly for adult and young birds based
on data from Old World bird species, with higher incidence
of circulating antibodies commonly found in adults (Rappole
et al. 2000). Despite being detected in dead specimens of at
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least 138 species of New World birds, low viremias in many
species suggests that WNV may only be a contributory factor
in what otherwise are natural deaths (Gerhardt 2006). West
Nile virus infection may require underlying illness, stress
or immunocompromise in a crane host to result in death
(Komar et al. 2003).
There did not appear to be any clusters of seropositive
cranes in this study that would suggest transmission via direct
contact, water or mechanical vectors (only 2 pairs exhibited
simultaneous seropositive tests in both individuals in a
given year). Meece et al. (2006) described a large outbreak
of WNV in exotic waterfowl that was likely propagated
by non-vector routes, particularly waterborne and direct
contact transmission (facilitated by behavioral factors such
as agonistic encounters and cannibalism) in overcrowded
conditions. At ICF, I expect that competent ornithophilic
mosquito vector(s) such as Culex sp. transmitted the virus to
the cranes (Hayes et al. 2005), but that the spatial and social
management of the flock (low host density, distinct pairs
with large pens, unoccupied buffer space surrounding each
pair, and limited surface water in bird areas), combined with
presumably poor host competence for virus amplification
(e.g., as established experimentally in American coots
[Fulica americana], Order Gruiformes; Komar et al. 2003),
limited both vector and non-vector transmission. To date,
no targeted mosquito control efforts have been considered
at ICF.
Preventive management of WNV in captive cranes at
ICF currently includes limited vaccination of hatch-year
whooping cranes based on concerns regarding susceptibility
to sub-clinical and overt disease in younger, cohort reared
cranes with developing immune systems. Vaccination of the
adult whooping crane flock at ICF should be taken under
consideration based on the incidence of positive WNV titers
in this species. Other preventive measures should include
common sense control of potential mosquito breeding
sites in crane areas (eliminating unneeded standing water
in containers or at construction sites etc.) and following
biosecurity measures between crane pens during daily
servicing routines (which also aids in preventing potential
occupational exposures).
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